BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28726046)

  • 1. Spectrophotometric photodynamic detection involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in voided urine.
    Nakai Y; Ozawa T; Mizuno F; Onishi S; Owari T; Hori S; Morizawa Y; Tatsumi Y; Miyake M; Tanaka N; Tsuruta D; Fujimoto K
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2309-2316. PubMed ID: 28726046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer.
    Nakai Y; Anai S; Onishi S; Masaomi K; Tatsumi Y; Miyake M; Chihara Y; Tanaka N; Hirao Y; Fujimoto K
    Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):282-8. PubMed ID: 25595357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.
    Cunderlíková B; Wahlqvist R; Berner A; Vasovic V; Warloe T; Nesland JM; Peng Q
    Cytopathology; 2007 Apr; 18(2):87-95. PubMed ID: 17397493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancer.
    Miyake M; Nakai Y; Anai S; Tatsumi Y; Kuwada M; Onishi S; Chihara Y; Tanaka N; Hirao Y; Fujimoto K
    Cancer Sci; 2014 May; 105(5):616-22. PubMed ID: 24602011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosensor device for the photo-specific detection of immuno-captured bladder cancer cells using hexaminolevulinate: An ex-vivo study.
    Chan KM; Vasilev K; Shirazi HS; McNicholas K; Li J; Gleadle J; MacGregor M
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():238-247. PubMed ID: 31394301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma.
    Yamamichi G; Nakata W; Tani M; Tsujimura G; Tsujimoto Y; Nin M; Mimura A; Miwa H; Tsujihata M
    Int J Clin Oncol; 2019 Sep; 24(9):1075-1080. PubMed ID: 30976938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
    Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
    J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL).
    Bader MJ; Stepp H; Beyer W; Pongratz T; Sroka R; Kriegmair M; Zaak D; Welschof M; Tilki D; Stief CG; Waidelich R
    Urol Oncol; 2013 Oct; 31(7):1178-83. PubMed ID: 22440147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
    Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG
    BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytology.
    Neuzillet Y; Methorst C; Schneider M; Lebret T; Rouanne M; Radulescu C; Molinie V; Dreyfus JF; Pelcat V; Botto H
    Urol Oncol; 2014 Nov; 32(8):1135-40. PubMed ID: 25023786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ferrochelatase has a strong correlation in protoporphyrin IX accumulation with photodynamic detection of bladder cancer.
    Nakai Y; Tatsumi Y; Miyake M; Anai S; Kuwada M; Onishi S; Chihara Y; Tanaka N; Hirao Y; Fujimoto K
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():225-232. PubMed ID: 26226642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses.
    Comploj E; Mian C; Ambrosini-Spaltro A; Dechet C; Palermo S; Trenti E; Lodde M; Horninger W; Pycha A
    Cancer Cytopathol; 2013 Jul; 121(7):392-7. PubMed ID: 23495066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
    BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrophotometric photodynamic diagnosis of prostate cancer cells excreted in voided urine using 5-aminolevulinic acid.
    Nakai Y; Miyake M; Anai S; Hori S; Tatsumi Y; Morizawa Y; Onisi S; Tanaka N; Fujimoto K
    Lasers Med Sci; 2018 Sep; 33(7):1557-1563. PubMed ID: 29725946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic diagnosis of shed prostate cancer cells in voided urine treated with 5-aminolevulinic acid.
    Nakai Y; Anai S; Kuwada M; Miyake M; Chihara Y; Tanaka N; Hirayama A; Yoshida K; Hirao Y; Fujimoto K
    BMC Urol; 2014 Aug; 14():59. PubMed ID: 25086448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical assessment of fluorescence cytoscopy during transurethral bladder resection in superficial bladder cancer.
    Jichlinski P; Wagnières G; Forrer M; Mizeret J; Guillou L; Oswald M; Schmidlin F; Graber P; Van den Bergh H; Leisinger HJ
    Urol Res; 1997; 25 Suppl 1():S3-6. PubMed ID: 9079749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
    Geavlete B; Multescu R; Georgescu D; Jecu M; Stanescu F; Geavlete P
    BJU Int; 2012 Feb; 109(4):549-56. PubMed ID: 21711438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: a new procedure with high sensitivity for detection of hardly visible urothelial neoplasias.
    Kriegmair M; Stepp H; Steinbach P; Lumper W; Ehsan A; Stepp HG; Rick K; Knüchel R; Baumgartner R; Hofstetter A
    Urol Int; 1995; 55(4):190-6. PubMed ID: 8588264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.